autoimmune encephalitis
Showing 1 - 25 of 2,047
Autoimmune Encephalitis Trial in Paris (FDG PET)
Not yet recruiting
- Autoimmune Encephalitis
- FDG PET
-
Paris, FranceHospital Pitie Salpetriere
Oct 16, 2023
FDG-PET in the Diagnosis of Autoimmune Encephalitis
Recruiting
- Autoimmune Encephalitis
- FDG-PET
-
Monza, Monza E Della Brianza, Italy
- +2 more
Aug 25, 2023
Diagnostic Score for Encephalitis to Assess Risk of Autoimmune
Recruiting
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
- Clinical score of Granillo and al.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023
Autoimmune Encephalitis Trial (Observational study)
Not yet recruiting
- Autoimmune Encephalitis
- Observational study
- (no location specified)
Jan 31, 2023
Neuro-ophthalmology and Autoimmune Encephalitis (NODE)
Recruiting
- Autoimmune Encephalitis
- oculomotor movement recordings, neurovisual assessment
-
Bron, FranceHospices Civils de Lyon
Jan 4, 2023
Immune-response in Autoimmune Encephalitis and Paraneoplastic
Recruiting
- Autoimmune Encephalitis
- Paraneoplastic Neurological Syndrome
- Genetic and immunology tests
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Mar 6, 2023
Acute Autoimmune Encephalitis With Positive Antibodies in
Recruiting
- Acute Autoimmune Encephalitis
-
Strasbourg, FranceService de Pédiatrie 1 - CHU de Strasbourg - France
Oct 28, 2022
Developing Advanced Neuroimaging for Clinical Evaluation of
Recruiting
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
- Autoimmune Encephalitis
- Not applicable - non-interventional study
-
London, Greater London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Jun 14, 2022
BRIEF TITLE * Role of MRI in Anti-LGI1 Encephalitis
Completed
- Autoimmune Encephalitis
- Retrospective evaluation of specific brain MRI features
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Apr 20, 2023
Auto-immune Encephalitis and Neurological Paraneoplastic
Active, not recruiting
- Paraneoplastic Neurological Syndrome
- Autoimmune Encephalitis
- Test of biological samples
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 12, 2023
Patient With Anti-GABAbr Antibodies Associated-encephalitis.
Completed
- Autoimmune Encephalitis
- Long-term outcome
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 14, 2023
Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis
Enrolling by invitation
- Autoimmune Encephalitis
- +2 more
-
Xi'an, Shaanxi, ChinaXijingH
Jun 20, 2022
GWAS in NMDAR Encephalitis
Recruiting
- Autoimmune Encephalitis
- GWAS
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 4, 2022
Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis Trial in Lyon (Collection of biological sample with sera, CSF,
Not yet recruiting
- Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis
- Collection of biological sample with sera, CSF, buffy coat, PBMC, plasma.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jan 6, 2022
Clinical Phenotypes and Outcomes of Ma2 Patient
Completed
- Autoimmune Encephalitis
- Paraneoplastic Syndromes
- Diagnosis test
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Dec 8, 2022
Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis Trial in Worldwide (Rozanolixizumab, Placebo)
Recruiting
- Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis
- Rozanolixizumab
- Placebo
-
Aurora, Colorado
- +21 more
Feb 2, 2023
Commercial Assay for the Detection of Neuronal Antibodies
Completed
- Paraneoplastic Neurological Syndrome
- Autoimmune Encephalitis
- Indirect immunofluorescence assay on tissue slides and cell-based assays with CSF and/or sera
-
Bron, France
- +1 more
Mar 13, 2023
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)
Not yet recruiting
- NMDAR Autoimmune Encephalitis
- LGI1 Autoimmune Encephalitis
- Satralizumab
- Placebo
-
Prague, Czechia
- +1 more
Aug 15, 2022
Autoimmune Encephalitis Trial in Dallas (Ocrelizumab, Saline)
Terminated
- Autoimmune Encephalitis
-
Dallas, TexasUT Southwestern Medical Center
Sep 21, 2021
Autoimmune Encephalitis Trial in Seoul (Erythropoietin)
Withdrawn
- Autoimmune Encephalitis
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 23, 2021
Autoimmune Encephalopathy Trial in Seoul (Vigabatrin 500 MG)
Withdrawn
- Autoimmune Encephalopathy
- Vigabatrin 500 MG
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 23, 2021
Status Epilepticus Trial in Chengdu (Perform autoimmune encephalitis titer tests)
Completed
- Status Epilepticus
- Perform autoimmune encephalitis titer tests
-
Chengdu, Sichuan, ChinaJie Liu
Dec 13, 2022